annual CFF:
$364.75M+$343.63M(+1627.29%)Summary
- As of today (July 1, 2025), CNTA annual cash flow from financing activities is $364.75 million, with the most recent change of +$343.63 million (+1627.29%) on December 31, 2024.
- CNTA annual CFF is now at all-time high.
Performance
CNTA Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$3.09M+$123.00K(+4.15%)Summary
- As of today (July 1, 2025), CNTA quarterly cash flow from financing activities is $3.09 million, with the most recent change of +$123.00 thousand (+4.15%) on March 31, 2025.
- Over the past year, CNTA quarterly CFF has dropped by -$7.41 million (-70.59%).
- CNTA quarterly CFF is now -98.75% below its all-time high of $245.98 million, reached on September 30, 2024.
Performance
CNTA quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$357.35M-$7.41M(-2.03%)Summary
- As of today (July 1, 2025), CNTA TTM cash flow from financing activities is $357.35 million, with the most recent change of -$7.41 million (-2.03%) on March 31, 2025.
- Over the past year, CNTA TTM CFF has increased by +$325.74 million (+1030.48%).
- CNTA TTM CFF is now -2.93% below its all-time high of $368.15 million, reached on September 30, 2024.
Performance
CNTA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CNTA Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1627.3% | -70.6% | +1030.5% |
| 3 y3 years | - | +4070.3% | +10000.0% |
| 5 y5 years | +3950.6% | - | - |
CNTA Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -98.8% | >+9999.0% | -2.9% | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | -98.8% | >+9999.0% | -2.9% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -98.8% | >+9999.0% | -2.9% | >+9999.0% |
CNTA Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $3.09M(+4.2%) | $357.35M(-2.0%) |
| Dec 2024 | $364.75M(+1627.3%) | $2.96M(-98.8%) | $364.75M(-0.9%) |
| Sep 2024 | - | $245.98M(+133.6%) | $368.15M(+168.9%) |
| Jun 2024 | - | $105.31M(+903.7%) | $136.91M(+333.1%) |
| Mar 2024 | - | $10.49M(+65.0%) | $31.61M(+49.7%) |
| Dec 2023 | $21.12M | $6.36M(-56.9%) | $21.12M(+42.2%) |
| Sep 2023 | - | $14.74M(>+9900.0%) | $14.85M(+4467.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $12.00K(>+9900.0%) | $325.00K(-15.1%) |
| Mar 2023 | - | $0.00(-100.0%) | $383.00K(-16.2%) |
| Dec 2022 | $457.00K(-66.4%) | $89.00K(-60.3%) | $457.00K(+24.2%) |
| Sep 2022 | - | $224.00K(+220.0%) | $368.00K(+155.6%) |
| Jun 2022 | - | $70.00K(-5.4%) | $144.00K(+94.6%) |
| Mar 2022 | - | $74.00K | $74.00K |
| Dec 2020 | $1.36M(-84.9%) | - | - |
| Dec 2019 | $9.01M | - | - |
FAQ
- What is Centessa Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals annual CFF year-on-year change?
- What is Centessa Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals quarterly CFF year-on-year change?
- What is Centessa Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals TTM CFF year-on-year change?
What is Centessa Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of CNTA is $364.75M
What is the all time high annual CFF for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high annual cash flow from financing activities is $364.75M
What is Centessa Pharmaceuticals annual CFF year-on-year change?
Over the past year, CNTA annual cash flow from financing activities has changed by +$343.63M (+1627.29%)
What is Centessa Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of CNTA is $3.09M
What is the all time high quarterly CFF for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high quarterly cash flow from financing activities is $245.98M
What is Centessa Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, CNTA quarterly cash flow from financing activities has changed by -$7.41M (-70.59%)
What is Centessa Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of CNTA is $357.35M
What is the all time high TTM CFF for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high TTM cash flow from financing activities is $368.15M
What is Centessa Pharmaceuticals TTM CFF year-on-year change?
Over the past year, CNTA TTM cash flow from financing activities has changed by +$325.74M (+1030.48%)